Furosemide Oral Solution Shortage
Areazine synthesizes this FDA drug-shortage notice directly from FDA's official public data feed. See our methodology for full source attribution and refresh cadence.
Furosemide Oral Solution is currently in shortage due to a shortage of an inactive ingredient, affecting all forms from Hikma Pharmaceuticals, with no estimated availability date.
What this FDA drug-shortage notice tells you, and what most readers miss
This notice was issued by FDA on April 7, 2026 and geographically references United States. Its severity classification of "high" signals how the issuing agency weighs the risk of harm if no action is taken - "critical" and "high" tier alerts typically carry direct consumer actions, while "medium" and "low" tend toward informational guidance or monitoring advisories. The category it belongs to - Drug Shortages - determines the regulatory framework behind it, which shapes what mitigations (alternative therapies, allocation timelines, manufacturer guidance) are available and which agency holds oversight.
Most readers skim a notice like this, check whether they are personally affected, and move on. The more useful lens is to verify its scope, source, and timestamp, then compare related notices without assuming that one record proves a broader trend.
Areazine pairs this record with the original agency URL so you can check the primary source before acting. Its related labels are drug-shortage, fda, medication, Furosemide.
Furosemide Oral Solution Shortage
What's in Shortage
The generic drug Furosemide Oral Solution, also known under the brand name FUROSEMIDE, is currently in shortage. It is available as an Oral Solution and falls under the Cardiovascular therapeutic category. The shortage status is current, with the initial posting date of 03/31/2026 and last updated on 03/31/2026.
Which Manufacturers Are Affected
The affected manufacturer is Hikma Pharmaceuticals USA, Inc., and all their presentations are unavailable:
- Furosemide, Oral Solution, 40 mg/5 mL (NDC 0054-3298-63): Unavailable, with estimated availability TBD, and contact information at 800-631-2174.
- Furosemide, Oral Solution, 10 mg/1 mL (NDC 0054-3294-50): Unavailable, with estimated availability TBD, and contact information at 800-631-2174.
- Furosemide, Oral Solution, 10 mg/1 mL (NDC 0054-3294-46): Unavailable, with estimated availability TBD, and contact information at 800-631-2174.
Why There's a Shortage
The shortage is due to a shortage of an inactive ingredient component.
What Patients Should Do
If you depend on Furosemide Oral Solution, consider talking to your pharmacist or healthcare provider about your options. You may also contact the manufacturer directly for updates. Remember, this information is not medical advice; always consult your healthcare provider for personalized guidance.
Source
This information is attributed to the FDA Drug Shortage Database.
Original source: FDA Official Notice ↗
Related Drug Shortages
All Drug Shortages →Nationwide notices with similar length or severity timing 8
Two Areazine-derived peer sets for this FDA drug-shortage notice: nearest notices by body length and by same severity near the same agency date. Peers come from other categories so they are not the same-feed Related list above.
Similar body length
Nearest notices by article body length (1,459 characters here).
Similar severity timing
Same severity (high) notices issued closest in time to April 7, 2026.
Frequently Asked Questions
Common questions about this FDA drug-shortage notice.